Sekisui Diagnostics Displays Full Range of Clinical Chemistry, Point-of-Care, and Biochemical Solutions

Exhibiting in Hall 1, Stand D57, the company draws on more than 40 years of global diagnostics expertise to support physicians, hospitals, laboratories, and decentralized testing environments.

At the booth, visitors can explore the OSOM rapid-test family, which provides fast, lateral-flow diagnostics for a wide range of infectious diseases, including influenza, Group A Strep, and Trichomonas vaginalis. For clinical chemistry, Sekisui is also highlighting its SEKURE reagent kits, which offer liquid-stable technology, strong performance, proven reliability, and comprehensive support services. Calibrators, controls, and linearity materials are also on display to complement instrument-based testing.

Sekisui is also prominently featuring point-of-care and home-testing solutions at MEDICA 2025. The OSOM brand extends into home-use products, including antigen- and molecular-based kits for COVID-19 and other respiratory pathogens. Sekisui also introduces its Metrix molecular platform and the Acucy diagnostic reader, both designed to support instrument-enabled point-of-care workflows in decentralized settings.

High-quality enzymes and specialty biochemicals form another key part of the portfolio, with products tailored for a variety of applications, including pharmaceutical manufacturing, clinical chemistry reagents, and POC/biosensor devices. The company is also highlighting its raw materials for plastic vacuum blood-collection tubes and related pre-analytic systems, which are trusted by blood-collection tube manufacturers worldwide. Sekisui’s raw materials offer excellent performance characteristics that support stable, reliable serum generation with very low influence on clinical test results, contributing to more accurate diagnostics and improved patient outcomes.

Related Links:
Sekisui Diagnostics